Sort
16,300 grants matching “fatty liver disease”
Sterile inflammation and pyroptotic cell death in liver fibrosis
$565,420Harold M Hoffman · University Of California, San Diego · R01 · FY2025 · DK
Phospholipid-Mediated Metabolic Control in the Pathogenesis of NAFLD
$565,399David E Cohen · Weill Medical Coll Of Cornell Univ · R01 · FY2020 · DK
gamma-OHPdG as a prognostic biomarker of HCC recurrence and its prevention
$565,396Fung-Lung Chung · Georgetown University · U01 · FY2020 · CA
The role of the Akt/PKB signaling in insulin action
$565,117Morris J Birnbaum · University Of Pennsylvania · R01 · FY2010 · DK
Adipsin in NASH
$564,949Utpal Pajvani · Columbia University Health Sciences · R01 · FY2024 · DK
Sterile inflammation and pyroptotic cell death in liver fibrosis
$564,949Harold M Hoffman · University Of California, San Diego · R01 · FY2024 · DK
Impact of GLP-1 on Hepatic Fat and Energy Utilization in Obese Girls with Polycystic Ovarian Syndrome
$564,886Melanie G Cree · University Of Colorado Denver · R01 · FY2019 · DK
Advancing 3D optical body surface scan technology to assess physiological and psychological effects in highly obese population
$564,766James K Hahn · George Washington University · R01 · FY2023 · DK
Clinical Research Network in NASH
$564,652Nathan M Bass · University Of California, San Francisco · U01 · FY2007 · DK
Novel pathways in the pathogenesis and pathophysiology of NAFLD in Hispanics
$564,499Sonia Michael Najjar · Ohio University Athens · R01 · FY2023 · MD
Genetic Regulation of Nonalcoholic Fatty Liver Disease
$564,108Marisa Wong Medina · University Of California, San Francisco · R01 · FY2022 · DK
Non-invasive screening of diabetics for advanced fibrosis due to NAFLD
$564,086Rohit Loomba · University Of California, San Diego · R01 · FY2020 · DK
Regional Fatty Acid Metabolism In Humans
$563,981Michael D. Jensen · Mayo Clinic Rochester · R01 · FY2017 · DK
TMEM55B as a molecular determinant of NAFLD
$563,952Marisa Wong Medina · University Of California, San Francisco · R56 · FY2024 · DK
Project 1 - Changes in Gut Microbiome and related Metabolome Across Trajectory of Alzheimer's Disease
$563,952Rima F Kaddurah-Daouk · Duke University · U19 · FY2022 · AG
A new mouse model for studying the pathogenesis and immunobiology of intrahepatic cholangiocarcinoma and improving its immunotherapy
$563,902Michael Karin · University Of California, San Diego · R01 · FY2023 · CA
Altered Lipid Droplet Trafficking: Role in Alcoholic Fatty Liver Disease
$563,876Carol A Casey · University Of Nebraska Medical Center · R01 · FY2020 · AA
Red Blood Cell Endothelial Nitric Oxide Attenuates Insulin Resistance
$563,804Francis Kim · University Of Washington · R01 · FY2021 · HL
Evaluation of PPARgam-sparing TZDs for Treating Non-Alcoholic Fatty Liver Disease
$563,804Rolf F Kletzien · Metabolic Solutions Development Co · R42 · FY2011 · AA
Metabolic impact of fructose restriction in obese children
$563,771Jean-Marc Schwarz · Touro University Of California · R01 · FY2011 · DK
Adipose Tissue Macrophage Phenotype and Function
$563,710Anthony W Ferrante · Columbia University Health Sciences · R01 · FY2024 · DK
Red Blood Cell Endothelial Nitric Oxide Attenuates Insulin Resistance
$563,702Francis Kim · University Of Washington · R01 · FY2020 · HL
Red Blood Cell Endothelial Nitric Oxide Attenuates Insulin Resistance
$563,669Francis Kim · University Of Washington · R01 · FY2019 · HL
Understanding and targeting bone marrow microenvironment in myelofibrosis
$563,550Lei Ding · Columbia University Health Sciences · R01 · FY2024 · HL
Assessing the Influence of the Human Lipidome on Risk of Diabetes in a Minority Population
$563,496Joanne E Curran · University Of Texas Rio Grande Valley · R01 · FY2021 · DK